One of the most common conditions among people today is high blood pressure or hypertension, and dietary changes can help reduce the risk or at the very least, keep blood pressure readings at bay. Aside from diet and exercise, supplements can also be taken to help it along.
Express reports that a supplement can be taken for people who suffer from hypertension in order to lower their readings. Probiotics can be taken in order to lower blood pressure readings. Through studies, the researchers found a link between probiotics - also known as the good kind of bacteria - and lowered blood pressure. Probiotics are mainly known to help promote a healthier digestive system resulting in better heart health. The good bacteria is also beneficial for those suffering from depression as well.
People can take probiotics through supplement forms, but they can also take it through the kind of food they eat. This can usually be found through fermented food, such as sauerkraut, kombucha, miso, and pickles. Yogurt is the most popular source of probiotics as it is made from milk that is fermented with such bacteria, and it can also result in better bone health.
Of course, a balanced diet and exercise can also greatly contribute to lowered blood pressure. Losing weight can also promote lowered blood pressure and improved quality of life. In terms of weight loss, people also use supplements to help promote the process of fat reduction. Glucomannan has been shown to be an effective supplement for weight loss.
This is because it is a natural dietary fiber coming from the roots of elephant yam or konjac. This supplement is known for being able to absorb water to the extent that one capsule of glucomannan can turn a single glass of water into a gel. This property also has benefits in terms of weight loss as well.
Glucomannan is also low-calorie and at the same time, it takes space in the stomach, giving the person a feeling of fullness and suppress appetite. Thus, less food is consumed, leading to weight loss. It also delays the emptying in the stomach and reduces the body’s absorption of protein and fat.


FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 



